COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 134 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2018. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $17,000 | -5.6% | 1,150 | 0.0% | 0.01% | -16.7% |
| Q4 2018 | $18,000 | +5.9% | 1,150 | 0.0% | 0.01% | +50.0% |
| Q3 2018 | $17,000 | -19.0% | 1,150 | 0.0% | 0.01% | -20.0% |
| Q2 2018 | $21,000 | -27.6% | 1,150 | 0.0% | 0.01% | -33.3% |
| Q1 2018 | $29,000 | +38.1% | 1,150 | 0.0% | 0.02% | +25.0% |
| Q4 2017 | $21,000 | +75.0% | 1,150 | 0.0% | 0.01% | +71.4% |
| Q3 2017 | $12,000 | -14.3% | 1,150 | 0.0% | 0.01% | -22.2% |
| Q2 2017 | $14,000 | +16.7% | 1,150 | 0.0% | 0.01% | +12.5% |
| Q1 2017 | $12,000 | -33.3% | 1,150 | 0.0% | 0.01% | -46.7% |
| Q4 2016 | $18,000 | -10.0% | 1,150 | 0.0% | 0.02% | -11.8% |
| Q3 2016 | $20,000 | +42.9% | 1,150 | 0.0% | 0.02% | +6.2% |
| Q2 2016 | $14,000 | -33.3% | 1,150 | 0.0% | 0.02% | -33.3% |
| Q1 2016 | $21,000 | +40.0% | 1,150 | +109.1% | 0.02% | +71.4% |
| Q4 2015 | $15,000 | – | 550 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,887,332 | $32,405,000 | 8.36% |
| SECTORAL ASSET MANAGEMENT INC | 1,156,934 | $19,865,000 | 2.70% |
| 1492 Capital Management LLC | 150,189 | $2,579,000 | 2.31% |
| Eventide Asset Management | 2,207,610 | $37,905,000 | 1.68% |
| J. Goldman & Co LP | 1,066,847 | $18,318,000 | 1.41% |
| HAMILTON LANE ADVISORS LLC | 89,975 | $1,545,000 | 1.35% |
| Rock Springs Capital Management LP | 1,605,105 | $27,560,000 | 1.30% |
| RICE HALL JAMES & ASSOCIATES, LLC | 932,126 | $16,005,000 | 0.58% |
| Opaleye Management Inc. | 80,000 | $1,373,000 | 0.51% |
| Cortina Asset Management, LLC | 456,036 | $7,830,000 | 0.48% |